Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-22

FDA Approved: ZEGALOGUE — Original Application (Novo Nordisk)

View source ↗

Summary

The FDA approved ZEGALOGUE (dasiglucagon) from Novo Nordisk in an Original Application for the treatment of severe hypoglycemia in adults and pediatric patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zegalogue (dasiglucagon)

Snippet

ORIG AP for ZEGALOGUE (DASIGLUCAGON)